Dr. Aggarwal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
70 Francis St
Boston, MA 02115Phone+1 617-667-7000
Education & Training
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2019 - 2022
Boston University School of MedicineClass of 2019
Certifications & Licensure
MA State Medical License 2019 - 2026- American Board of Internal Medicine Internal Medicine
Clinical Trials
- ZEN-3694, Enzalutamide, and Pembrolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer Start of enrollment: 2021 Jan 26
Publications & Presentations
PubMed
- 106 citationsRacial/Ethnic Disparities in Hypertension Prevalence, Awareness, Treatment, and Control in the United States, 2013 to 2018.Rahul Aggarwal, Nicholas Chiu, Rishi K. Wadhera, Andrew E. Moran, Inbar Raber
Hypertension. 2021-04-19 - 7 citationsGeneralizability of FIGARO-DKD and FIDELIO-DKD Trial Criteria to the US Population Eligible for Finerenone.Nicholas Chiu, Rahul Aggarwal, George L Bakris, Bertram Pitt, Deepak L Bhatt
Journal of the American Heart Association. 2022-04-05 - 6 citationsGeneralizability of DAPA-CKD to the United States.Rahul Aggarwal, Nicholas Chiu, Deepak L. Bhatt
Circulation. Cardiovascular Quality and Outcomes. 2021-06-22
Press Mentions
Empagliflozin Confers Kidney-Protective Benefits After Acute MISeptember 10th, 2024- What You Need to Know About CKM, the Link Between Heart Health, Diabetes and Kidney DiseaseMay 19th, 2024
- Diabetes Often Leads to Heart and Kidney Disease, TooMay 15th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
